Granolio d.d. za proizvodnju, trgovinu i usluge financials
Granolio d.d. za proizvodnju, trgovinu i usluge
213800O3Z6ZSDBAKG321 | Line item | 2024 | 2023 |
|---|---|---|
| Income statement | ||
| Revenue | €94.4M | €86.7M |
| Other income | €6.7M | €4.0M |
| Employee benefits expense | €8.7M | €7.0M |
| Depreciation & amortisation | €3.6M | €3.3M |
| Operating profit (EBIT) | €7.2M | €3.9M |
| Net finance income / (cost) | -€992.0K | -€787.0K |
| Finance costs | €1.5M | €848.0K |
| Profit before tax | €6.2M | €3.1M |
| Income tax expense | €623.0K | €633.0K |
| Profit for the year | €5.6M | €2.4M |
| — attributable to owners | €4.2M | €1.9M |
| — attributable to NCI | €1.4M | €550.0K |
| Total comprehensive income | €5.6M | €2.4M |
| Cash flow statement | ||
| Cash generated from operations | €4.4M | €9.3M |
| Net cash from operating activities | €2.9M | €7.8M |
| Net cash from investing activities | -€14.7M | -€9.6M |
| Purchase of PP&E (capex) | €17.6M | €6.4M |
| Net cash from financing activities | €9.8M | €439.0K |
| Dividends paid | €500.0K | €800.0K |
| Proceeds from borrowings | €21.1M | €7.4M |
| Repayments of borrowings | €10.6M | €5.9M |
| Lease liability payments | €35.0K | €0 |
| Net change in cash | -€2.0M | -€1.4M |
| Balance sheet | ||
| Total assets | €88.8M | €65.9M |
| Right-of-use assets | €339.0K | €450.0K |
| Trade & other receivables | €15.8M | €13.0M |
| Cash & equivalents | €505.0K | €2.5M |
| Total equity | €28.4M | €23.4M |
| — attributable to owners | €23.4M | €19.2M |
| Non-controlling interests | €5.0M | €4.1M |
| Long-term borrowings | €531.0K | €265.0K |
| Lease liabilities (non-current) | €226.0K | €332.0K |
| Lease liabilities (current) | €119.0K | €163.0K |
| Deferred tax liabilities | €1.2M | €1.2M |
| Derived metrics | ||
| Free cash flow | -€14.7M | €1.4M |
| Operating margin | 7.6% | 4.5% |
| Net margin | 5.9% | 2.8% |
| Return on equity | 19.7% | 10.5% |
| Cash conversion ratio | 0.52× | 3.19× |
| Capex coverage | 0.17× | 1.21× |
| Other reported items | ||
| Adjustments For Decrease Increase In Biological Assets | €556.0K | €489.0K |
| Adjustments For Decrease Increase In Inventories | -€6.5M | €1.5M |
| Adjustments For Decrease Increase In Loans and Advances To Customers | -€94.0K | €737.0K |
| Adjustments For Decrease Increase In Trade and Other Receivables | -€5.9M | €1.9M |
| Adjustments For Depreciation and Amortisation Expense | €3.6M | €3.3M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Loans and Advances | -€57.0K | -€225.0K |
| Adjustments For Increase Decrease In Trade and Other Payables | €6.5M | -€1.3M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €390.0K | €297.0K |
| Basic Earnings Loss Per Share From Continuing Operations | €2.19 | €0.99 |
| Biological Assets | €1.0M | €998.0K |
| Buildings | €23.0M | €17.7M |
| Capital Redemption Reserve | €110.0K | €106.0K |
| Capital Reserve | €11.2M | €11.2M |
| Cash Advances and Loans Made To Other Parties Classified As Investing Activities | €441.0K | €3.7M |
| Cash Flows From Used In Operations Before Changes In Working Capital | €10.3M | €6.4M |
| Cash Receipts From Repayment of Advances and Loans Made To Other Parties Classified As Investing Activities | €3.0M | €385.0K |
| Changes In Inventories of Finished Goods and Work In Progress | €14.0K | €470.0K |
| Construction In Progress | €8.0M | €2.4M |
| Current Advances | €1.0M | €1.1M |
| Current Borrowings and Current Portion of Noncurrent Borrowings | €4.5M | €3.8M |
| Current Financial Assets | €2.8M | €5.3M |
| Current Interest Payable | €487.0K | €0 |
| Current Loans and Receivables | €1.5M | €4.1M |
| Current Loans Received and Current Portion of Noncurrent Loans Received | €3.0M | €3.4M |
| Current Notes and Debentures Issued and Current Portion of Noncurrent Notes and Debentures Issued | €166.0K | €166.0K |
| Current Payables On Social Security and Taxes Other Than Income Tax | €654.0K | €902.0K |
| Equity and Liabilities | €88.8M | €65.9M |
| Expense By Nature | €93.9M | €86.8M |
| Finance Income | €522.0K | €61.0K |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | €5.0K | €3.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €440.0K | €714.0K |
| Increase Decrease Through Appropriation of Retained Earnings | €0 | €0 |
| Increase Decrease Through Sharebased Payment Transactions | -€4.0K | — |
| Increase Decrease Through Transfer Between Revaluation Reserve and Retained Earnings | €0 | €0 |
| Intangible Assets Other Than Goodwill | €1.4M | €501.0K |
| Interest Paid Classified As Operating Activities | €1.1M | €800.0K |
| Interest Received Classified As Investing Activities | €417.0K | €44.0K |
| Inventories Total | €14.7M | €7.9M |
| Investment Property | €846.0K | €670.0K |
| Issued Capital | €2.5M | €2.5M |
| Land | €2.1M | €1.9M |
| Miscellaneous Other Operating Expense | €1.5M | €1.1M |
| Noncurrent Financial Assets | €385.0K | €249.0K |
| Noncurrent Financial Assets At Fair Value Through Profit Or Loss Classified As Held For Trading | €375.0K | €225.0K |
| Noncurrent Loans and Receivables | €10.0K | €24.0K |
| Noncurrent Payables To Related Parties | €1.3M | €0 |
| Noncurrent Payables To Trade Suppliers | €254.0K | €827.0K |
| Noncurrent Portion of Noncurrent Loans Received | €22.5M | €14.0M |
| Noncurrent Portion of Noncurrent Notes and Debentures Issued | €333.0K | €499.0K |
| Noncurrent Prepayments | — | €185.0K |
| Other Cash Receipts From Sales of Interests In Joint Ventures Classified As Investing Activities | -€93.0K | €0 |
| Other Current Payables | €7.0K | €51.0K |
| Other Current Receivables | €2.0M | €449.0K |
| Other Expense By Nature | €1.5M | €1.3M |
| Other Financial Assets | €20.0K | €20.0K |
| Other Property Plant and Equipment | €16.0K | €10.0K |
| Proceeds From Government Grants Classified As Financing Activities | €4.0K | €0 |
| Profit Loss From Continuing Operations | €5.6M | €2.4M |
| Repayments of Bonds Notes and Debentures | €166.0K | €246.0K |
| Retained Earnings Excluding Profit Loss For Reporting Period | -€1.1M | -€3.3M |
| Retained Earnings Profit Loss For Reporting Period | €4.2M | €1.9M |
| Revaluation Surplus | €5.3M | €5.7M |
| Revenue and Operating Income | €101.1M | €90.7M |
| Shortterm Employee Benefits Accruals | €592.0K | €448.0K |
| Statutory Reserve | €1.2M | €1.1M |
| Trade and Other Current Payables To Related Parties | €117.0K | €1.1M |
| Trade and Other Current Payables To Trade Suppliers | €20.2M | €10.7M |
| Trade and Other Current Receivables Due From Related Parties | €651.0K | €635.0K |
Every line item above is a fact tagged in Granolio d.d. za proizvodnju, trgovinu i usluge's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.